Fürstenau, M., Bahlo, J., Fink, A. M., Lange, E., Dreger, P., Dreyling, M., . . . Eichhorst, B. (2020). Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia. Leukemia, 34(3), . https://doi.org/10.1038/s41375-019-0597-3
Chicago-Zitierstil (17. Ausg.)Fürstenau, Moritz, et al. "Residual Abdominal Lymphadenopathy After Intensive Frontline Chemoimmunotherapy Is Associated with Inferior Outcome Independently of Minimal Residual Disease Status in Chronic Lymphocytic Leukemia." Leukemia 34, no. 3 (2020). https://doi.org/10.1038/s41375-019-0597-3.
MLA-Zitierstil (9. Ausg.)Fürstenau, Moritz, et al. "Residual Abdominal Lymphadenopathy After Intensive Frontline Chemoimmunotherapy Is Associated with Inferior Outcome Independently of Minimal Residual Disease Status in Chronic Lymphocytic Leukemia." Leukemia, vol. 34, no. 3, 2020, https://doi.org/10.1038/s41375-019-0597-3.